ICM
PLPC icon

Invenomic Capital Management’s Preformed Line Products PLPC Stock Holding History

Invenomic Capital Management’s Portfolio PLPC Stock Details PLPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-31,478
Closed -$1.94M – 182
2022
Q2 		$1.94M Buy
31,478
+179
+0.6% +$11.1K 0.14% 124
2022
Q1 		$1.63M Buy
31,299
+8,682
+38% +$520K 0.17% 111
2021
Q4 		$1.46M Buy
22,617
+471
+2% +$30.8K 0.31% 91
2021
Q3 		$1.44M Buy
22,146
+2,475
+13% +$174K 0.47% 69
2021
Q2 		$1.46M Sell
19,671
-206
-1% -$14.8K 0.35% 63
2021
Q1 		$1.37M Hold
19,877
– – 0.3% 64
2020
Q4 		$1.36M Buy
19,877
+4,684
+31% +$271K 0.35% 62
2020
Q3 		$740K Buy
15,193
+1,237
+9% +$65.5K 0.41% 77
2020
Q2 		$698K Hold
13,956
– – 0.52% 67
2020
Q1 		$696K Buy
13,956
+90
+0.6% +$4.76K 0.57% 59
2019
Q4 		$837K Buy
+13,866
New +$864K 0.34% 84

Other funds holding PLPC

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $27.4B AUM 24.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invenomic Capital Management's PLPC Position: Q3 2022 in Review

Invenomic Capital Management sold out of Preformed Line Products (PLPC) in Q3 2022, closing a stake of 31,478 shares — an estimated $1.94M sold.

Invenomic Capital Management first reported a position in PLPC in Q4 2019 and held it in 11 quarters. The position peaked at $1.94M in Q2 2022. 92 funds tracked by Wall St. Rank hold PLPC as of Q3 2022.

  • Invenomic Capital Management reported no remaining Preformed Line Products position as of Q3 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 31,478 Preformed Line Products shares in Q3 2022, an estimated $1.94M.
  • Invenomic Capital Management first reported a position in Preformed Line Products in Q4 2019 and held it in 11 quarters.
  • Invenomic Capital Management's Preformed Line Products position peaked at $1.94M in Q2 2022.
  • 92 funds tracked by Wall St. Rank held Preformed Line Products as of Q3 2022.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.